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https://doi.org/10.101most commonly performed procedures in the United States are the Roux-en-Y gastric bypass and
the sleeve gastrectomy, which involve significant anatomic and physiologic alterations that lead to
changes in behavior and biology. Unfortunately, many patients experience suboptimal weight loss
and/or substantial weight regain. Eating and physical activity/sedentary behaviors, mood, cognition,
and the gut microbiome all change postoperatively and have an association with weight change. The
longitudinal relationship between changes in the gut microbiome and postoperative weight trajectory
has not been explored thoroughly, and the interactive associations among the gut microbiome and the
other variables that impact weight have been similarly understudied.
The following is a methods and design description for a prospective, 24-month longitudinal study of
144 bariatric surgery patients, at 2 sites, that aimed to identify predictors of weight loss trajectories
over 24 months after Roux-en-Y gastric bypass and the sleeve gastrectomy. Specifically, the study
will examine the relationships between empirically supported behavioral and biological variables
and their combined impact on postoperative weight trajectories. Novel data collection will include
intensivemeasurement of problematic eating behaviors and diet and physical activity postoperatively,
which may be altered in parallel with, or in response to, changes observed in the gut microbiota. Iden-
tifying postoperative predictors of weight loss and co-morbidity resolution should inform develop-
ment of novel interventions that are tailored to individual patients’ risk profiles to optimize and
sustain more favorable weight trajectories. (Surg Obes Relat Dis 2020;16:1816–1826.)  2020
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The most effective treatment for severe obesity is bariat-
ric surgery [1], with the Roux-en-Y gastric bypass (RYGB)
and the sleeve gastrectomy (SG) being the most commonly
performed procedures in the United States [2]. However, the
multisite Longitudinal Assessment of Bariatric Surgery
study found that a significant subset of patients (w25%),
do not achieve expected weight loss outcomes [3]. Reviews
also suggest that most patients regain some weight with
approximately 20% regaining the majority of lost weight
[4]. These suboptimal outcomes can result in lack of
improvement or recurrence of medical co-morbidity [5,6].
Prior research has shown significant associations between
weight loss after bariatric surgery and variables involving
eating pathology, such as “loss of control” eating [5,7–9],
“grazing,” eating when not hungry [5,10,11], nocturnal
eating, and stress-induced eating [5,10–12]. Residual
depressive symptoms also have been shown to negatively
impact weight outcomes [13] as has lower physical activity
and higher sedentary behavior [14–16]. Differences in
executive function may impact eating, adherence, and
physical activity [17].
Beyond behavioral variables, biological factors—namely
the gut microbiome—have been a recent area of focus in the
context of bariatric surgery. Human and animal work have
established obesity-associated permutations in the gut
microbiota with some studies demonstrating causal relation-
ships between specific changes in the gut microbiota and
weight loss [18]. Numerous anatomic and physiologic
changes follow RYGB and SG that may contribute to
changes in the microbial flora of the distal gut. Prospective
research show increases in specific phyla, such as Proteo-
bacteria, after RYGB that consistently correlate with
changes in weight, serum leptin, and variably with inflam-
mation markers including C-reactive protein [19]. The ratio
of Firmicutes to Bacteroidetes has been shown to decrease
after RYGB after controlling for sex, age, and medication
[19]. Of note, past studies have not adequately controlled
for dietary intake. This is considered to be a significant defi-
ciency of the extant literature [20]. The collective body of
evidence suggests there is bidirectional communication
between the gut microbiome and brain function (i.e., the
gut–brain axis) [21], which may impact behavior, but this
interface has not been well studied in bariatric samples.
Aims of the BioBehavioral Trial
The contributors to suboptimal weight loss or regain af-
ter bariatric surgery are poorly understood and likely
involve complex interactions between behavioral and bio-
logical variables. Our first aim was to describe the pro-
spective relationships among weight change and
variations in postoperative problematic eating behaviors,
physical activity/sedentary behaviors, mood, and cogni-
tive function, and whether these relationships are moder-
ated by surgical procedure. We hypothesize that patientswho report fewer problematic eating behaviors, greater
levels of physical activity/lower levels of sedentary
behavior, less depressive symptoms, and better cognitive
function, will experience a more favorable weight loss tra-
jectory and greater percent excess weight loss (%EWL) at
24 months after surgery. Furthermore, we hypothesize that
these relationships will be stronger for participants
receiving RYGB versus SG. Aim 2 characterized the pro-
spective relationships between postoperative weight tra-
jectory and changes in the composition of the gut
microbiome and further explore whether this relationship
is moderated by surgical procedure. We hypothesized that
the presence and abundance of specific taxa within the in-
testinal microbiota will be demonstrated in patients who
experience the most favorable weight outcomes and great-
est 24-month %EWL, and that these relationships will be
moderated by surgical procedure. A final exploratory aim
assessed whether the microbiome gut–brain axis is a
mechanistic determinant of weight trajectory after bariat-
ric surgery. We hypothesized that changes in the composi-
tion of the gut microbiome would mediate the relationship
between weight trajectory after RYGB or SG and behav-
ioral variables of interest. This aim, within a longitudinal
study, allowed us to begin to better understand the interac-
tion between biological and behavioral variables on
explaining weight loss trajectories.Methods
This study was designed as a prospective, longitudinal
assessment of behavioral, psychological, and biological fac-
tors temporally related to weight loss trajectory over 2 years
after RYGB or SG. It was submitted to NIDDK in response
to RFA-DK-16-017 (Psychosocial and Behavioral Mecha-
nisms in Bariatric Surgery). Data collection occurs at two
sites (Sanford Center for Biobehavioral Research [CBR],
in collaboration with North Dakota State University, in
Fargo, ND; and Cleveland Clinic Bariatric and Metabolic
Institute, Cleveland, OH. Inability to engage in physical ac-
tivity or dietary monitoring Self-report Recruitment takes
place through the Sanford Eating and Weight Management
Center through an established collaborative relationship
with the Neuropsychiatric Research Institute in Fargo,
ND, and through the Cleveland Clinic Bariatric and Meta-
bolic Institute, Cleveland, OH.
Participants and recruitment
Participants who are in the evaluation process for RYGB
and SG are offered the opportunity to volunteer for this
study. A total of 144 participants undergoing bariatric sur-
gery (w50% RYGB and 50% SG) will be enrolled in this
study. In anticipation of a rate of attrition of approximately
30%, this enrolled sample is expected to yield a final sample
size of 100, which will provide adequate power to address
the stated hypotheses. Enrolled participants are assessed at
baseline (presurgery) and specified time points (1, 6, 12,
18, 24 mo) after surgery (Fig. 1).
Recruitment takes place through REDACTED FOR
BLIND REVIEW in REDACTED FOR BLIND REVIEW,
and through the REDACTED FOR BLIND REVIEW.
Criteria for enrollment were carefully considered and cho-
sen to balance generalizability with the need to reduce
some confounding variables (Table 1). Additional data
that could influence the microbiome are collected and will
be used as covariates in analyses if appropriate (e.g., co-
morbid medical conditions, medication use, surgical history
[especially of cholecystectomy/appendectomy], nutritional
supplement use, etc.).
Study assessments and timeline
Screening visit
Participants who provide informed consent at a presurgi-
cal evaluation visit in the bariatric clinic are screened for
study eligibility by research staff according to the list of in-
clusion and exclusion criteria (Table 1). All criteria are in
place to protect participant safety and to avoid introducing
unnecessary confounding variables into the study data. At
screening, each participant completes a medical history to
assess for inclusion/exclusion criteria. Participants also
have the first Structured Clinical Interview (SCID-5) [22]
administered during the screening visit to assess for psycho-










































EDE-BSV=Eating Disorders Examination—Bariatric Surge
BSSQ= Bariatric Surgery Self-Management Questionnaire
PA=Physical Activity
ASA-24=The ASA24 Automated Self-administered 24-Hou
SCID-1=Structured Clinical Interview for DSM-5)
BDI-1=The Beck Depression Inventory 1
Fig. 1. Schedule of stuwho meet all eligibility crtieria are invited to enroll in the
study and complete study assessements according to the
schedule described below. Participants are required to com-
plete study baseline assessments before beginning any pre-
scribed presurgical diet.
Study visits (presurgery and 1, 6, 12, 18, and 24 mo
postsurgery)
With the exception of the stuctured clinical interview for psy-
chological disorders, all assessments are completed at each
study visit (Fig. 1). The following assessments are completed:
Measures and variables of interest
Weight, %EWL, body mass index
Height and weight data are collected at each study visit.
Participants are weighed in light clothing without shoes.
Participants’ ideal weight is calculated based upon a body
mass index (BMI) 5 25 at baseline to facilitate determina-
tion of %EWL after surgery. To facilitate comparison be-
tween studies, data are recorded in weight (lbs, kg), body
BMI units (kg/m2), and %EWL.
Dietary recall: the ASA24 automated self-administered
24-hour
The ASA24 dietary recall was developed by the National
Cancer Institute. The ASA24 has been validated for research
use and offers a web-based platform for the collection
of automated, self-administered, 24-hour dietary recalls%EWL









































Inclusion criteria Method of assessment
Male or female between the ages of 18 and 65 yr, inclusive Photo identification
In evaluation for Roux-en-Y gastric bypass or sleeve gastrectomy as primary procedure Surgery department
Planning to be available for 2 yr of follow-up after surgery Self-report
Exclusion criteria Method of assessment
Alcohol or substance use disorder in the past year Structured interview
Severe psychiatric disorder that may affect the ability of the participant’s ability to comply with
the protocol
Structured interview
Tobacco use in the prior year Self-report
Current medication known to significantly influence gastrointestinal transit time (e.g., opioids,
glucagon-like peptide-1 agonists, metoclopramide) or is being taken routinely for weight
loss (e.g., phentermine, topiramate)
Medical history
Use of any oral or injectable antibiotic in the past month Medical history
Use of commercially available prebiotic or probiotic in the past month Medical history
History of significant intestinal disease or disorder that would influence the microbiome (e.g.,
Crohn’s disease, etc.)
Medical history
History of significant gastrointestinal surgery that would influence the microbiome, not
including cholecystectomy or appendectomy
Medical history
Inability to engage in physical activity or dietary monitoring or any medical condition that
would put the participant at risk in the study
Self-report
Positive urine drug screen for a nonprescribed medication Urine drug screen
Pregnancy or breast feeding Self-report(food, fluids, vitamins, and supplements). The ASA24 is
based upon the U.S. Department of Agriculture Automated
Multiple-Pass Method, which is validated and provides ac-
curate estimations of mean total energy and protein con-
sumption in biomarker testing [23,24]. The system has
been used widely in nutrient research and is considered
the gold standard method of assessment of food intake. Par-
ticipants completed 3 days of dietary recall at each study
visit.
Psychological assessment
The Structured Clinical Interview for DSM-5 [22] is a
structured interview that is used as a diagnostic tool for psy-
chiatric disorders following DSM-5 criteria. Psychological
assessors on this protocol have regular meetings to ensure
high interrater reliability on administration of the SCID.
The Beck Depression Inventory [25] is a 21-item self-
report measure that assesses current depression level and
symptoms of depression. It is a widely used and established
measure with demonstrated reliability and validity [26].
Higher scores on the Beck Depression Inventory reflect
higher levels of depression and, more broadly, negative
affect [27]. There is a detailed protocol and safety plan for
any acute psychiatric symptoms or suicidality.
Problematic eating behaviors and adherence to
recommendations
The Eating Disorders Examination-Bariatric Surgery Version
(EDE-BSV) [7] is a clinical interviewmeasure adapted from the
EDE interview [28] for use in bariatric surgery samples. TheEDE is considered to have the best validity and reliability in
assessing eating disordered behavior and the EDE-BSV contains
additional items that are specific to the concerns of weight loss
surgery patients (e.g., dumping, plugging, etc.). Similar to the
SCID, assessors meet regularly to ensure high interrater reli-
ability. For the Bariatric Surgery Self-Management Question-
naire [29], participants complete the questionnaire, a 33-item
questionnaire regarding adherence to prescribed behaviors spe-
cific to bariatric surgery. This measure asks about adher-
ence over the previous week in eating behaviors,
physical activity, dumping syndrome management, intake
of fluids, supplements, fruits/vegetables/whole grains,
and protein. Subscales for each domain, as well as a total
score, are converted to a 0 to 99 range. Higher scores indi-
cate better adherence. Internal consistency of the Bariat-
ric Surgery Self-Management Questionnaire in bariatric
samples is a 5 .83 [29].
Physical activity—objective measurement of physical
activity
Participants’ daily time spent in physical activity and
sedentary behavior (SB) at the different pre- and postopera-
tive assessment periods is measured using the newest gener-
ation Actigraph monitor (i.e., ActiGraph GT9 X Link [AG];
Actigraph, LLC, Pensacola, FL, USA). The AG device is
worn on the waist and combines a rigorously validated
triaxial accelerometer with several advanced new features,
including a wear time sensor (to detect if the device has
been removed) and a secondary accelerometer, gyroscope,
and magnetometer that together provide highly advanced
data on movement, rotation, and body position (note: the
AG’s liquid crystal display window display for providing
real-time participant feedback will be deactivated during as-
sessments). The AG is shown to reliably measure physical
activity and SB in adults over 7 days in free-living condi-
tions [30]. Data from the AG are processed using ActiLife
software version 6.11.3 (ActiGraph, LLC). Participants are
asked to wear the AG on the waist during all waking hours,
exclusive of bathing and swimming, for 7 consecutive days
at each assessment period [31]. Participants are required to
provide 4 days of data (including 1 weekend day), defined
as 600 minutes of wear time during the hours of 7 AM to
11 PM, to be included in analyses. Variables of primary in-
terest will include (1) total and bout-related moderate-to-
vigorous physical activity, and (2) percent of daily time
spent in SB overall and that accumulated in bouts (e.g.,
30 min) to capture the prolonged nature of SB and related
metabolic health risks [32,33].
Cognitive assessment
The National Institutes of Health Toolbox for the Assess-
ment of Neurologic and Behavioral Function [34] was
developed to assess (via a computer platform) cognitive
function across the lifespan and promote generalizability
of study findings across researchers. Specific measures
used are consistent with those found in our past work to pre-
dict weight loss outcomes in bariatric surgery patients
[35,36] and include the following assessments.
Attention/executive function
The Dimension Change Card Sort Test is similar to the
Wisconsin Card Sort Task and assesses hypothesis testing
and ability to change mental set in the face of new contin-
gencies. The Flanker Inhibitory Control and Attention
Test is similar to the Erikson flanker task and require partic-
ipants make rapid decisions about the direction of target
stimuli. The List Sorting Working Memory Test requires
attending to a string of visual and auditory information
and reciting them back in predetermined order.
Memory
The Picture Sequence Memory Test asks individuals to
learn and remember pictured objects and their actions on
the screen.
Processing speed
The Pattern Comparison Processing Speed Test asks par-
ticipants to quickly identify if the 2 visual patterns are the
same or different.
Language
The Picture Vocabulary Test is an adaptive measure of
receptive vocabulary and asks individuals to match words
to target pictures among a collection of foils.Gut microbiome assessment
Fecal collection
Fecal material is collected by each individual enrolled in
our study. At the commencement of our study, and at each
study visit, participants are provided a fecal sample collec-
tion kit and study cooler. For each study visit participants
have the option to provide a fecal sample at the time of
the study visit or may do so at home if desired. If home sam-
ple collection is preferred, participants are asked to bring the
sample to the research facility, on ice/ice packs, within 24
hours of collection. Samples are labeled and stored at
280C until analysis. Each sample is transported to the mo-
lecular microbiology laboratory on dry ice where it is me-
chanically homogenized using a sterile spatula and
aliquoted into as many 2-mL cryo-tubes as can be filled.
The tubes are then labeled and immediately stored in a
280C freezer. The same procedures are used to obtain sub-
sequent longitudinal samples from individuals 1, 6, 12, 18,
and 24 months postsurgery.
Isolation of microbial DNA
Microbial DNA are isolated from intestinal tissue and fecal
material using a phenol/chloroform extraction method com-
bined with physical disruption of bacterial cells and a DNA
clean-up kit (Qiagen DNeasy Blood and Tissue extraction kit;
Qiagen, Valencia, CA, USA) as previously described [37].
The composition of the microbiome will be assessed through
16 S high-throughput sequencing as well as through a more
comprehensive metagenomic shotgun sequencing approach.
High-throughput sequencing of 16 S rRNA genes
Bacterial community composition in isolated DNA from
intestinal tissue and fecal material are characterized by
amplification of the V6 variable region of the 16 S rRNA
gene by polymerase chain reaction (forward: 5’-CAACGC-
GARGAACCTTACC-3’; reverse: 5’-CAACACGAGCT-
GACGAC-3’) and sequencing both 5’ and 3’ ends using
the Illumina HiSeq 2500 platform at the high-throughput
sequencing core at University of North Carolina at Chapel
Hill as previously described [38].
Analysis of 16 S rRNA sequences using the DADA2 Pipeline
16 S rRNA sequence data generated by the Illumina HiSeq
2500 platform will be processed by the Divisive Amplicon
Denoising Algorithm 2 (DADA2) pipeline [39], which iden-
tifies sequence variants at a 100% identity threshold. Sequence
variants will be assigned to a taxonomy using a DADA2-
formatted reference database (silva_nr_v128_train_set.fa.gz).
Read counts at each taxonomic level will be normalized using
a formula as previously described to account for different
sequencing depths across samples [40]. Shannon diversity in-
dex, a measurement of within-sample diversity (a-diversity),
will be calculated using the “diversity” function from the vegan
package in R (The R Project for Statistical Computing, Vienna,
Austria). Principal coordinate analysis (PCoA) will be used to
visualize between-sample diversity (b-diversity) in the micro-
bial composition. PCoA will be performed using Bray-Curtis
dissimilarity indices and the “capscale” function from the
vegan package in R.
Analysis of 16 S rRNA sequences using the quantitative
insights into microbial ecology pipeline
16 S rRNA sequence data generated by the Illumina
HiSeq 2500 platform will be processed by the quantitative
insights into microbial ecology pipeline as previously
described [41]. Sequences will be clustered into operational
taxonomic units based on a 97% sequence similarity
(similar to species level) using UCLUST [42,43]. Opera-
tional taxonomic units will be assigned to a taxonomy using
the Ribosomal Database Project Naive Bayes classifier [44].
The percentages of specific bacterial taxa in each sample
will be summarized at 6 levels (phylum, class, order, family,
genus, and species). Microbial richness measures will be
generated by rarefaction of 16 S rRNA sequences and
expressed as (1) the number of observed operational taxo-
nomic units in each sample, and (2) the Shannon index of
diversity. PCoA for each sample using unweighted and
weighted UniFrac distances [45] will also be generated.
PCoAs define the similarities or dissimilarities of variables
that best represent the pair-wise distances between samples.
Metagenomic shotgun sequencing
We will use the Illumina HiSeq 4000 platform at the
REDACTED FOR BLIND REVIEW high throughput
sequencing facility to complete whole-genome shot-gun
sequencing. This approach will be used to characterize the
microbiome of all participants at each time point of data
collection. Metagenomic data analysis will occur in collabo-
ration with the University of North Carolina Charlotte.Meta-
genomic DNA sequences will be decontaminated from
human genomes using KneadData (http://huttenhower.sph.
harvard.edu/kneaddata). The decontaminated sequences
will be taxonomically classified using the Kraken2 [46]
through an automated pipeline BiolockJ (https://github.
com/msioda/BioLockJ). Microbial read counts at each taxo-
nomic level will be normalized as described for the 16 S
rRNA sequencing data. Microbial gene families and gene
pathwayswill be characterized using the pipeline HUManN2
and abundances will be normalized using the HUMAnN2
tool renorm table [47]. Similar to the 16 S rRNA sequencing
data,a- andb- diversitywill be calculated by ShannonDiver-
sity Index and Bray-Curtis dissimilarity, respectively. PCoA
will be used to visualize dissimilarities between samples us-
ing the “capscale” function in R.
Collection of additional information that may influence the
microbiome
At study visits, additional data are recorded, which may
influence the microbiome, including the use of allmedications, gastrointestinal surgery history, and menstrual
cycle status.
Ethics and informed consent
The study protocol was reviewed and approved by the
institutional review board at both sites. Written informed
consent from the patient is obtained before beginning the
initial study visit. The current protocol has been registered
on the National Institutes of Health’s clinicaltrials.gov
website.
Statistical analyses and sample size estimation
Preliminary analyses
Descriptive statistics and frequency distributions will be
examined for all screening data, as well as key measures ob-
tained at each assessment. Descriptive statistics will be
compiled for the overall sample, as well as separately by
site. Distribution diagnostics and outlier analyses will be per-
formed on key variables to inform decisions about the transfor-
mation of measures for subsequent analyses. Proportional
hazards regression analyses [48] will be used to evaluate
whether baseline demographic characteristics or clinical char-
acteristics are associated with study retention. Missing value
analyses will be performed to identify missing data patterns
and evaluate possible mechanisms for missing data (i.e.,
missing completely at random, missing at random, missing
not at random). Variables that are associated with early dropout
or missing data will be considered for use as covariates in sub-
sequent analyses to minimize potential biases associated with
missing data. Analyses will be performed to compare key base-
line and clinical characteristics by site and surgical procedure.
Significant differences between groups will help to inform the
specifics of the analyses below as well as the use of covariates.
Hypothesis testing
Hypothesis 1a
Patients who report fewer problematic eating behaviors,
greater levels of physical activity, less mood symptoms,
and better cognitive function, will experience a more favor-
able weight loss trajectory longitudinally after RYGB or SG
and greater %EWL from preoperative baseline to 24-months
postoperatively.
Linear mixed-effects time-lagged models with random
intercepts and slopes will be used to evaluate the prospective
predictors of weight trajectory. The longitudinal portion of
the model will be constructed following the guidelines of
Singer and Willet [49], where alternative methods for
modeling time (e.g., unconditional means model, uncondi-
tional linear growth model, and various unconditional
nonlinear models) will be compared using the Akaike Infor-
mation Criterion. Predictors will then be added to the model
as time-varying effects and will be time-lagged such that
predictors at time 1 will be used to predict weight at time
2, controlling for time 1 weight. Models will include both
the main effects for predictors, as well as the predictor !
time interaction(s). Preliminary models will evaluate predic-
tors separately. A multivariate model will then be con-
structed using significant univariate predictors.
Hypothesis 1b
Surgical procedure (RYGB versus SG) will moderate the
relationship between eating behavior, physical activity,
mood, cognitive function, and weight outcome such that
these relationships will be stronger for participants receiving
RYGB compared with those receiving SG.
The moderating effects of surgical procedure will be eval-
uated by adding a main effect for surgical procedure, as well
as procedure ! predictor and procedure ! predictor !
time interaction(s) to the models above.
Hypothesis 2a
The presence and abundance of specific taxa within the
intestinal microbiota will be associated with patients who
experience the most favorable weight outcomes and greatest
24-month %EWL postsurgery.
The prospective association between intestinal micro-
biome predictors and weight trajectories will be evaluated
using linear mixed-effects time-lagged models comparable
to those described for Hypothesis 1.
Hypothesis 2b
Surgical procedure (RYGB versus SG) will moderate the
relationship between the composition of the intestinal micro-
biome and postsurgicalweight outcomeswhereinRYGBwill
more strongly influence the relationship between the micro-
biome and weight outcome compared with SG.
The moderating effects of surgical procedure will be eval-
uated by adding a main effect for surgical procedure, as well
as procedure ! predictor and procedure ! predictor !
time interaction(s) to the models above.
Hypothesis 3
Changes in the composition of the gut microbiome will
mediate the relationship between weight trajectory after
RYGB or SG and eating and physical activity behaviors,
mood, and cognitive function.
Multilevel structural equation modeling [50] with random
slopes will be used to evaluate the mediating effects of
changes in the gut microbiome. A 1-1-1 MSEM model
(referring to the measurement level of the independent,
mediator, and dependent variable, respectively) will be con-
structed with predictors at time 1 as the independent vari-
able, changes in gut microbiome from time 1 to time 2 as
the mediator, weight at time 2 as the dependent variable,
and weight at time 1 as a covariate. This model provides
nonconflated estimates of both the between- and within-
patients indirect effects.
For exploratory analyses, linear mixed-effects time-
lagged models with random intercepts and slopes will beused to evaluate whether weight trajectories differ as a func-
tion of baseline age, sex, surgergy type (RYGB versus SG),
or the presence or absence of type 2 diabetes.
Power analysis for Hypotheses 1a and 2a were based upon
multilevel Monte Carlo simulations using Mplus version 6
software [51]. Simulations assumed an unconditional linear
model, 6 assessment points, a 30% attrition rate over the 24-
month period, and a 2-tailed alpha of .05. The magnitude of
the predictor main effect was then varied until the null hy-
pothesis of no indirect effect was rejected on 80% of the
10,000 replications (i.e., .80 power). The proposed enrolled
sample size of n 5 144 (with w100 completing the study)
provides a statistical power of .80 to detect a standardized
predictor effect of .21. Sample size estimates for Hypothe-
ses 1b and 2b were obtained by adding a predictor ! sur-
gery procedure interaction to the simulation models
described above and then systematically varying the magni-
tude of the interaction effect until a power of .80 was ob-
tained. The proposed sample size of 144 provides a
statistical power of .80 to detect a standardized interaction
effect of .34. Power analyses for Hypothesis 3 were based
upon the methods described by Fritz and MacKinnon for
determining a required sample size to detect a mediated ef-
fect [52]. Using the bias-corrected bootstrap method, a sam-
ple of size of 71 would provide adequate power (.80) to
detect medium effects (.39) for both the a path (IV to medi-
ator) and the b path (mediator to DV). Thus, the proposed
enrolled sample of 144 (w100 study completers) provides
sufficient power to evaluate the mechanistic role of the
gut–brain microbiome.
Trial status
The trial was successfully registered on clinical trials.gov
on February 27, 2017 and the institutional review board
approved the study on February 9, 2017 (Cleveland) and
12/19/2016 (Fargo). Recruitment began on June 20, 17 in
Cleveland and June 1, 2017 in Fargo. Seventy-nine partici-
pants at Cleveland and 70 participants at Fargo have been
enrolled (over enrollment is because of participants having
baseline visits but not proceeding to surgery). The final
24-month assessments for all participants are anticipated
to occur by the spring of 2022.
Discussion
Although bariatric surgery is the most effective and dura-
ble treatment for severe obesity, outcomes are variable and
many experience weight regain. Research has yet to estab-
lish mechanisms for weight regain although a number of
behavioral and biological variables have been posited. The
study’s overarching goal is to optimize bariatric surgery
weight loss outcomes through identification of key mecha-
nisms that can be targeted for intervention.
This will be the first prospective, longitudinal study to
carefully examine the biobehavioral contributors to bariatric
surgery weight loss trajectory. Most studies have been
limited by short follow-up periods and small sample sizes.
In contrast, the current sufficiently powered study includes
postoperative follow-up assessments that capture multiple
points before weight nadir (1, 6 mo), approaching weight
nadir (12 mo), and after weight nadir when weight regain
may occur (18, 24 mo) [3]. In addition, the majority of
extant data involves either behavioral or biological etiol-
ogies rather than using an integrated approach. Limited
existing evidence suggests bidirectional communication be-
tween the microbiome and brain function both in times of
homeostasis and disease [21]. This communication seems
to occur primarily through complex interactional effects in
the hypothalamic–pituitary–adrenal axis and structures in
the central nervous system that can affect cognition,
mood, and emotion. There are currently very few data
addressing the relationship between postbariatric surgery
changes in the gut microbiota on behavior, and this prospec-
tive study will allow us to investigate the gut–brain axis
through detailed and comprehensive assessments of the
gut microbiota, psychopathology, eating behavior, food
intake, and cognition.
This study will help answer whether the gut microbiome
changes in response to diet and whether there are associa-
tions between the gut microbiome and problematic eating
behaviors. The dramatic changes in nutrient intake that
follow bariatric surgery are expected to alter the composi-
tion of the gut microbiome. Dietary intake over long periods
of time plays a major role in shaping the composition and
determining the diversity of the intestinal microbiota. The
combined approach of 16 S and metagenomic shotgun
sequencing will allow us to examine both taxonomic and
functional changes to the microbiome that occur in response
to surgery.
An increasing literature is exploring the likely bidirec-
tional relationship between eating behavior and the gut
microbiome. Among animal studies, yo-yo dieting may be
as unhealthy as a steadily poor diet [53]. To date, there are
limited data concerning the effects of anorexia nervosa on
the microbiome [54–56], but the influence of binge eating
on the intestinal microbiome remains an empirical
question, and one that is being addressed in the present study.
The gut microbiome also appears to be sensitive to
changes in physical activity. The majority of studies exam-
ining the effects of exercise on the intestinal microbiota,
however, have been conducted in animal models and shows
that exercise affects the diversity of the intestinal micro-
biome, especially the Bacteroidetes and Firmicutes phyla
[57–60] and have not assessed this relationship in a
bariatric sample
Furthermore, a growing number of studies have suggested
that the gut microbiome plays a role in depression [61–63].
Inducing depression-like states in mice, has been found to
result in measurable changes to the intestinal microbiome
[64]. It appears that the gut microbiome also has thecapacity to influence mood and anxiety symptoms [21]. Us-
ing 6 data collection time points spanning from before to 24
months after surgery, we will be able to characterize the
temporal relationships between changes in the microbiota
and changes in mood. Necessary future studies will be
able to build upon data collected in this study, with the
aim of exploring the gut–brain axis in greater detail among
bariatric surgery patients. In particular, given the high rates
of mood disorders present in the bariatric surgery population
and the recurrence of mood symptoms that often occurs
distal to surgery, it is particularly important to focus on clar-
ifying mechanisms responsible for enduring or relapsing
symptoms.
A growing number of studies also suggest that the gut
microbiome is an important contributor to cognitive func-
tion. Though the mechanisms remain incompletely under-
stood, gut–brain communication is mediated through
multiple systems, including numerous cytokines [65].
Mice assigned to a high sucrose diet exhibit a greater reduc-
tion in Bacteroidetes and poorer performance on a measure
of cognitive flexibility [66]. Similarly, mice receiving
microbiome transplantation from those prescribed a high-
fat diet show poorer learning of new information and explor-
atory behavior than controls [67]. Few studies have directly
examined the relationship between the gut microbiome and
cognitive function in humans. An initial study in persons
with cirrhosis compared those with and without hepatic en-
cephalopathy and revealed a pathway from dysbiosis of
microbiome to inflammatory processes to cognitive
dysfunction in those with hepatic encephalopathy [68]. We
have recently generated additional evidence of a positive as-
sociation between cognition and the gut microbiome [69].
The present study will help elucidate the interaction be-
tween biological and behavioral variables and may be
used as a framework from which to begin additional more
detailed mechanistic assessments between specific signifi-
cant associations with the gut microbiome and variables of
interest after bariatric surgery.
This study will address limitations in previous, smaller in-
vestigations of the gut microbiome in bariatric surgery pa-
tients that may contribute to inconsistency among
findings. Inconsistent results of prior studies may be attrib-
utable to several factors. There have been variations in study
design, laboratory techniques used to characterize the
microbiome, and sample sizes have generally been small.
Additionally, limited attention has been given to controlling
variables that may confound study results, such as dietary
intake [20]. The consistent identification of changes in the
microbiota of the gut after bariatric surgery, coupled with
the inconsistent findings with respect to the downregulation
or proliferation of specific bacterial species, supports the
need for additional well-controlled research in this area.
Each of these limitations will be strengthened by the present
study proposal, which involves detailed collection of dietary
intake information.
The data captured in this study will be instrumental in
moving toward precision medicine in bariatric surgical
care. We will use these data to identify predictors of postsur-
gical weight loss outcome so that at-risk patients can be
identified and preventative and therapeutic interventions
can be implemented in a timely fashion. These data will
also serve as the basis for designing subsequent psychother-
apeutic and pharmacologic weight regain prevention and
treatment options to help optimize bariatric surgery out-
comes. Ultimately, these data may help to elucidate the
mechanism(s) responsible for weight change and weight
recidivism after bariatric surgery, which may help in the
future development of nonsurgical, less invasive treatment
options for severe obesity.
Challenges and design considerations
This study provides one approach to collecting data on
the gut microbiome in the bariatric surgery population.
This patient population presents numerous challenges to
the collection of data on the gut microbiome, and requires
a careful balance between limiting confounds and maintain-
ing generalizability. Among the most significant design con-
siderations was whether or not to exclude common disease
states or surgical histories that are relatively common but
may influence the gut microbiota, and importantly, may
also change after surgery (e.g., diabetes, hypertension, his-
tory of cholecystectomy). Ultimately, we elected to include
all disease states except those which are relatively rare
among this patient population and expected to dramatically
influence the gut microbiota (e.g., colon resection). Other
major design considerations surrounded which medications
to include as exclusionary criteria. Ultimately, the study
team established a list of medications that would be ex-
pected to have a profound influence on the gut microbiota
when taken routinely, and which may not be controllable
analytically because of low base rates of use and possible
changes from pre- to postsurgery in use, such as
glucagon-like-peptide agonists, opioids, potent anticholin-
ergics, and a few others with empirical or theoretic impact
on the microbiome. Acid-reducing medications, despite
their known impact on the microbiota, were permitted
because of their pervasive use among this population. An
additional major variable we elected to control for by
excluding participants or carefully timing baseline data
collection was presurgery weight loss medications and die-
tary prescriptions (i.e., liquid diet before surgery), which we
expected to have a major impact on weight trajectory and
the gut microbiota.Conclusions
Overall, this prospective, multicenter study will provide
data from a large sample of bariatric surgery patients who
are followed for 2 years postoperatively. Data will includecomprehensive and validated assessments of behavior,
along with assessment of the gut microbiome using contem-
porary shotgun sequencing methodology. We will be able to
compare these relationships among patients who undergo
RYGB with those who undergo SG. These data will provide
an important framework from which to develop subsequent
more targeted protocols exploring specific aspects of the gut
microbiome and its mechanistic influence on bariatric
surgery outcomes. Although the focus of this study is on
postbariatric surgery weight outcomes, data concerning
obesity-associated co-morbidity resolution and reoccur-
rence are also being collected. Increasingly, data suggest
that the gut microbiome is an important regulator of
obesity-associated co-morbidities, such as diabetes and car-
diovascular disease. Data collected through this study may
pave the way to more tailored investigations exploring the
mechanisms through which the gut microbiota impacts
various disease states and psychopathology.
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